Jonathan Bornstein, President of Amprius Lab at Amprius Technologies, Inc. (AMPX), sold 300,000 shares at $4.32 ($1.3M) on 2024-01-02, disclosed to the SEC on 2024-01-04.
Scheduled sale ($1.3M) by President of Amprius Lab under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.32 | 124,634 | $538K | 40.4% |
| 2 | $4.32 | 124,634 | $538K | 40.4% |
| 3 | $5.05 | 25,366 | $128K | 9.6% |
| 4 | $5.05 | 25,366 | $128K | 9.6% |
| Total | $4.44 avg | 300,000 | $1.3M | 100% |
| Filing → |
| AMPX | SELL | 2024-08-22 | $19K | — | Filing → |
| AMPX | SELL | 2024-05-24 | $27K | — | Filing → |
| AMPX | SELL | 2024-04-03 | $600K | — | Filing → |